TGFB1 and breast carcinoma: TGF-β1/SMAD/HLF-activated IL-6 in TNBC cells induces a TAM-like phenotype via the JAK/STAT3 pathway and further upregulates TGF-β 1 expression, constituting a feedback circuit that promotes breast cancer ferroptosis resistance [168].